TLR3 and neoplasm: DNMTis stimulate the production of HERV-derived dsRNA in tumor cells, trigger IFN responses through the MAD5 or TLR3 signaling pathways, induce tumor cell apoptosis, and enhance immune infiltration (Figure 4A) [15,91].